ARS Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $13.5M | $13.0M | $563.0K | $14.5M |
| FY2025 | $-170.9M | $-171.2M | $339.0K | $22.1M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $13.5M | $13.0M | $563.0K | $14.5M |
| FY2025 | $-170.9M | $-171.2M | $339.0K | $22.1M |